PanOptica Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:PanOptica Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10859
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PanOptica Inc (PanOptica) is a clinical-stage biopharmaceutical company that develops topical eye drops for the treatment of sight-threatening eye diseases. The company concentrates on candidates that are at or near the investigational new drug application stage. It develops PAN-90806, a novel, topically applied, once daily eye drop for the treatment of wet AMD and other neovascular eye diseases. PanOptica’s drugs are used in sight-threatening eye diseases caused by abnormal or leaky blood vessels. The company also partners biopharmaceutical companies to complete development, regulatory approval, and commercialization of the compound. PanOptica is headquartered in Bernardsville, New Jersey, the US.

PanOptica Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PanOptica Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PanOptica Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PanOptica Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PanOptica Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
PanOptica Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
PanOptica Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
PanOptica Raises Additional USD11 Million in Series B Financing 10
PanOptica Secures USD23.88 Million in Venture Funding 11
PanOptica Raises US$45 Million In Series B Financing 12
PanOptica Inc – Key Competitors 14
PanOptica Inc – Key Employees 15
PanOptica Inc – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
PanOptica Inc, Pharmaceuticals & Healthcare, Key Facts 2
PanOptica Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PanOptica Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PanOptica Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PanOptica Inc, Deals By Therapy Area, 2012 to YTD 2018 8
PanOptica Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
PanOptica Raises Additional USD11 Million in Series B Financing 10
PanOptica Secures USD23.88 Million in Venture Funding 11
PanOptica Raises US$45 Million In Series B Financing 12
PanOptica Inc, Key Competitors 14
PanOptica Inc, Key Employees 15

List of Figures
PanOptica Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
PanOptica Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
PanOptica Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
PanOptica Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
PanOptica Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PanOptica Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
PanOptica Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PanOptica Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[PanOptica Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Clean Diesel Technologies Inc (CDTI):企業の財務・戦略的SWOT分析
    Summary Clean Diesel Technologies Inc (CDTI) is a clean technology company that manufactures and distributes heavy duty diesel and light duty vehicle emissions control systems and products to automakers and retrofitters. The company's products include catalyst products, heavy duty diesel products, a …
  • Lees Foods Ltd.:企業の戦略・SWOT・財務情報
    Lees Foods Ltd. - Strategy, SWOT and Corporate Finance Report Summary Lees Foods Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Serina Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Serina Therapeutics Inc (Serina Therapeutics) is a drug company that develops therapeutics for cancer, inflammation, pain, and metabolic disorders. The company’s pipeline product includes SER-214, SER-226, SER-228, SER-232, and other proprietary drugs. It uses proprietary technology, polyoxa …
  • Ergon Inc:企業の戦略的SWOT分析
    Ergon Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Molecular Warehouse Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Molecular Warehouse Ltd (Molecular Warehouse) is a developer of proteins for diagnostic and therapeutic use. The company helps prevent diseases by empowering people with molecular diagnostics. Its synthetic biology techniques enabled it to reengineer glucose dehydrogenase, and enzymes found …
  • F-Secure Oyj (FSC1V):企業の財務・戦略的SWOT分析
    F-Secure Oyj (FSC1V) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Generali France S.A.:企業の戦略・SWOT・財務分析
    Generali France S.A. - Strategy, SWOT and Corporate Finance Report Summary Generali France S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Power Corporation of Canada:企業の戦略・SWOT・財務情報
    Power Corporation of Canada - Strategy, SWOT and Corporate Finance Report Summary Power Corporation of Canada - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • The Wharf (Holdings) Limited
    The Wharf (Holdings) Limited - Strategy, SWOT and Corporate Finance Report Summary The Wharf (Holdings) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Experian PLC (EXPN):企業の財務・戦略的SWOT分析
    Experian PLC (EXPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Staples Inc:企業の戦略的SWOT分析
    Staples Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Athena Investments AS (ATHENA):電力:M&Aディール及び事業提携情報
    Summary Athena Investments AS(Athena), Previously known as Greentech Energy System A/S is an energy company which operates renewable energy plants. It generates electricity from wind and solar sources. Through long-term power purchase agreements, the company sells electricity. Athena expands its ass …
  • Smrt Corporation Ltd.:企業の戦略・SWOT・財務分析
    Smrt Corporation Ltd. - Strategy, SWOT and Corporate Finance Report Summary Smrt Corporation Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Volta River Authority-エネルギー分野:企業M&A・提携分析
    Summary Volta River Authority (VRA) is a state-owned energy utility that generates, transmits, and distributes electricity. The authority produces power from solar, hydro, light crude oil, distillate fuel oil, and heavy fuel oil sources. It procures energy from Takoradi International Company Ltd; an …
  • AstraZeneca PLC:企業の戦略・SWOT・財務情報
    AstraZeneca PLC - Strategy, SWOT and Corporate Finance Report Summary AstraZeneca PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Rajesh Exports Limited:企業の戦略・SWOT・財務分析
    Rajesh Exports Limited - Strategy, SWOT and Corporate Finance Report Summary Rajesh Exports Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Meridian Bioscience Inc (VIVO)-製薬・医療分野:企業M&A・提携分析
    Summary Meridian Bioscience Inc (Meridian) is a fully integrated life science company that carries out the development, manufacturing and distribution of diagnostic test kits for gastrointestinal, viral, respiratory, and parasitic infectious disease indications. It also manufactures bulk antigens, a …
  • 3D Systems Corporation:戦略・SWOT・企業財務分析
    3D Systems Corporation - Strategy, SWOT and Corporate Finance Report Summary 3D Systems Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Laboratoire Aguettant SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Laboratoire Aguettant SA (Aguettant) is a pharmaceutical company that that focuses on the development, manufacturing and commercialisation of injectable hospital medicines. The company offers sterile injectable medicines in various dosages and pharmaceutical forms. It provides its products f …
  • MISC Berhad (MISC):石油・ガス:M&Aディール及び事業提携情報
    Summary MISC Bhd (MISC), a subsidiary of Petroliam Nasional Berhad (Petronas), is an international energy shipping and maritime conglomerate. The company is a fully integrated maritime, offshore floating solution, heavy engineering and logistics service provider. Its principal business activities in …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆